StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $18.00 price objective on shares of Can-Fite BioPharma in a research report on Thursday, May 9th. […]
Can-Fite BioPharma (NYSE:CANF) Coverage Initiated by Analysts at StockNews.com modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report released on Thursday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reiterated a buy rating and set a $18.00 price target on shares of Can-Fite BioPharma in a research report on Thursday, May 9th. Get […]
Stock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of NYSE CANF opened at $2.09 on Tuesday. The company has a market capitalization […]
Investment analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Price Performance Can-Fite BioPharma stock opened at $2.09 on Tuesday. Can-Fite BioPharma has a one year low of $1.76 and […]